PATENT CLAIM ANALYSIS

Application Number: 16052724
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2019-06
Patent Classification: ["514", "549000"]

Abstract:
In various embodiments, the present invention provides methods of treating and/or preventing pediatric metabolic syndrome comprising administering to a subject in need thereof a pharmaceutical composition comprising eicosapentaenoic acid or a derivative thereof.

Claim (Index 6):
The method of  claim 1 , wherein the subject has three or more of: (a) an impaired glucose tolerance as determined by having two-hour glucose levels of 140 mg/dL to 199 mg/dL on the 75-gram oral glucose tolerance test; (b) a body mass index (\u201cBMI-Z\u201d) score of at least 2.0 based on an age and a gender associated with the subject; (c) a triglyceride level in at least the 95th percentile based on the age, the gender and a race associated with the subject; (d) an HDL-C level in no more than the 5th percentile based on the age, the gender, and the race associated with the subject; and (e) a blood pressure level in at least the 95th percentile based on the age, gender and height associated with the subject.

Metadata:
- Claim Count in Document: 14.0
- Percentile: 96.0
- Lexical Diversity: 1.12903
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13282145', '13711329', '13349157', '13349153', '13711324']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7195347415679088
- 35 USC 102 Novelty (BERT): 0.520228714427606
- Combined Prediction Score: 0.6996041388538785
- Mean Citation Score: 291.38515399999994
- Max Citation Score: 292.50858
- Similarity Product: 211.1225719485354

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test